Acute Decompensated HF Drugs 2 Flashcards
Medical Factors Contributing to Decompensation
Noncompliance with meds or dietary restrictions MI, Arrhythmia (afib), uncontrolled HTN, or valvular diseases
Pharmacological Factors Contributing to Decompensation
Over-diuresis with diuretics Negative inotrope of beta blockers, Non-DHP CCB, itraconazole or Class 1 anti-arrhythmic Certain chemotherapies NSAIDs (Na/H20 retention) Glitazones and steroids bc of fluid retention
B-type naturetic peptide (BNP)
Increases with fluid overload bc of distention of heart chambers Less than 50 = fluid overload unlikely 100-500: fluid overload possible >500 Fluid overload very likely
BNP things to keep in mind
Can be elevated in age, myocardial hypertrophy, myocardial stress, and renal dysfunction
Invasive hemodynamic monitoring
Swan-Ganz catheter or pulmonary artery catheter
PAOP
without HF 6-10 >18 = fluid overload/congestion (need for diuresis)
CI
without HF 3-4 Less than 2.2 with cold signs and symptoms (may need vasodilators or inotropes)
Swan-Ganz Catheters can cause
Arrhythmias, thrombosis, infection, bleeding, pneumothorax or rupture of pulmonary artery
CHF meds might be
Reduced or temporarily discontinued if entering the hospital bc of HF but they need to be re-initiated after especially ACEi, BB, Aldosterone antagonists
ACEi/Aldosterone antagonists reduce the dose or d/c if…
Hypotension Hyperkalemia > 5.5 Worsening renal function (increasing SCr or decreased urine output)
Beta-blockers reduce the dose or d/c if:
Hypotension Requiring inotropes - Stopping increases likelihood of arrhythmias and mortality (start low and go slow when re-starting)
Define Warm and Dry
Volume status is normal and cardiac output is adequate Maintain or optimize chronic oral meds and fluid status
Warm and Dry Patients should be counseled on:
Don’t take NSAIDs if your weight is increasing BB may make you feel works before you get better and have some long-term benefits
Define Warm and Wet
Volume status is increased but cardiac output is adequate Symptoms of congestion (edema, orthopnea) No symptomsof low cardiac output PAOP > 15-18; Cardiac Index > 2.2
Warm and Wet patients need
to be diuresised
Warm and Wet General management strategy
Decrease weight by 1-1.5 kg/d (avoid decrease in renal function) Start IV loop diuretic Double dose Coninuous infusion Add thiazide Add vasodilator Consider Swan-Ganz or possible inotrope Last line: hypofiltration
Define Cold and Dry
Volume status is normal or low Cardiac ouput is decreased No symptoms of congestion Symptoms of decreased cardiac output (decreased renal function, altered mental status, cold/cyanotic extremities) PAOP 15-18 or less Cardiac Index less than 2.2
Cold and Dry Management Strategy
Ensure volume status is adequate then add inotrope to main CI > 2.2 Give NS 250-500 mL IV x2 (if improve, pt is dehydrated) Insert Swan-Ganz to determine fluid status and CI Give IV fluids to increase PAOP to ~15 Then start inotrope if CI still less than 2.2
Dobutamine/Milirone can be used in Cold and Dry if
BP > 90/60
Noreepinephrine if
BP is less than 90/60 (titrate to BP of 90/60 - Add dobutamine if CI is still less than 2.2
Define Cold and Wet
Volume status is increase Cardiac output is decreased Symptoms of congestion Symptoms of decreased cardiac output PAOP >18 CI less than 2.2
Cold and Wet Management strategy:
Fix underlying cause Maintain BP over 90/60 Slowly remove excess volume with diuretics
Cold and Wet SBP >110
Diuretic + Vasodilator - If BP drops below 110 stop the vasodilator and add inotrope - If CI is less than 2.2 or no improvement with vasodilator, add or switch to inotrope - Nitropresside or nitroglycerin and then start diuretics
Cold and Wet SBP 90-110
Diuretic + Inotrope - Dobutamine (less than 90) or milrinone if >90 (acts like a vasodilator in HF)
Cold and Wet SBP Less than 90
NE to maintain BP > 90/60 - If cardiac index is less than 2.2 add dobutamine and slowly diurese (avoid hypotension) - Cardiogenic shock - Get of NE ASAP
Goals of Therapy
Identify and correct precipitating factors ID and improve hemodynamic status Optimize CHF therapy to reduce mortality